Sommaire

Numéro précédent | Numéro suivant

• • ·Title Page

    Page :i

    
• • ·Faculty List

    Page :vi

    Plan Plan
• • ·Faculty Disclosures

    Page :xii

    
• • ·Introduction

    Page :S1

    Robert P. Byington, Saul Genuth, William T. Friedewald, Denise G. Simons-Morton

     
• • ·Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

    Page :S4

    David C. Goff, Hertzel C. Gerstein, Henry N. Ginsberg, William C. Cushman, Karen L. Margolis, Robert P. Byington, John B. Buse, Saul Genuth, Jeffrey L. Probstfield, Denise G. Simons-Morton, ACCORD Study Group †

    Résumé Résumé Plan Plan
• • ·Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

    Page :S21

    John B. Buse, The ACCORD Study Group ⁎ †

    Résumé Résumé Plan Plan
• • ·Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

    Page :S34

    Hertzel C. Gerstein, Matthew C. Riddle, David M. Kendall, Robert M. Cohen, Robin Goland, Mark N. Feinglos, Julienne K. Kirk, Bruce P. Hamilton, Faramarz Ismail-Beigi, Patricia Feeney, ACCORD Study Group †

    Résumé Résumé Plan Plan  
• • ·Rationale and Design for the Blood Pressure Intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

    Page :S44

    William C. Cushman, Richard H. Grimm, Jeffrey A. Cutler, Gregory W. Evans, Sarah Capes, Marshall A. Corson, Laurie S. Sadler, Michael H. Alderman, Kevin Peterson, Alain Bertoni, Jan N. Basile, ACCORD Study Group †

    Résumé Résumé Plan Plan  
• • ·Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

    Page :S56

    Henry N. Ginsberg, Denise E. Bonds, Laura C. Lovato, John R. Crouse, Marshall B. Elam, Peter E. Linz, Patrick J. O’Connor, Lawrence A. Leiter, Daniel Weiss, Edward Lipkin, Jerome L. Fleg, ACCORD Study Group †

    Résumé Résumé Plan Plan
• • ·Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

    Page :S68

    Connie Kingry, Arnaud Bastien, Gillian Booth, Therese S. Geraci, Brenda R. Kirpach, Laura C. Lovato, Karen L. Margolis, Yves Rosenberg, JoAnne M. Sperl-Hillen, Laura Vargo, Jeff D. Williamson, Jeffrey L. Probstfield, ACCORD Study Group †

    Résumé Résumé Plan Plan  
• • ·Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

    Page :S80

    Denise E. Bonds, Ella Mae Kurashige, Richard Bergenstal, David Brillon, Michael Domanski, James V. Felicetta, Vivian A. Fonseca, Kathleen Hall, Irene Hramiak, Michael E. Miller, Kwame Osei, Denise G. Simons-Morton, ACCORD Study Group †

    Résumé Résumé Plan Plan  
• • ·Health-Related Quality of Life and Cost-Effectiveness Components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design

    Page :S90

    Mark D. Sullivan, Roger T. Anderson, David Aron, Hal H. Atkinson, Arnaud Bastien, G. John Chen, Patricia Feeney, Amiram Gafni, Wenke Hwang, Lois A. Katz, K.M. Venkat Narayan, Chuke Nwachuku, Patrick J. O’Connor, Ping Zhang, ACCORD Study Group †

    Résumé Résumé Plan Plan
• • ·Rationale, Design, and Methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE)

    Page :S103

    Emily Y. Chew, Walter T. Ambrosius, Letitia T. Howard, Craig M. Greven, Samantha Johnson, Ronald P. Danis, Matthew D. Davis, Saul Genuth, Michael Domanski, ACCORD Study Group †

    Résumé Résumé Plan Plan
• • ·The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): Rationale, Design, and Methods

    Page :S112

    Jeff D. Williamson, Michael E. Miller, R. Nick Bryan, Ronald M. Lazar, Laura H. Coker, Janice Johnson, Tali Cukierman, Karen R. Horowitz, Anne Murray, Lenore J. Launer, ACCORD Study Group †

    Résumé Résumé Plan Plan